March 17, 2020 C-Path to Lead Multi-Stakeholder Engagement on FDA’s Proposed Novel Framework to Enhance the Pediatric Medical Device Ecosystem TUCSON, Ariz., March 17, 2020 — The Critical Path Institute (C-Path) today announced it has been awarded a grant to condu
March 12, 2020 C-Path Appoints Dr. Klaus Romero as Chief Science Officer TUCSON, Ariz., March 12, 2020 — The Critical Path Institute (C-Path) today announced the appointment of Klaus Rome
March 12, 2020 C-Path Selects Experienced Neuroscientist to Lead Alzheimer’s Consortium TUCSON, Ariz., March 12, 2020 — The Critical Path Institute (C-Path) today announced it has named Sudhir Sivakumar
January 29, 2020 ERA4TB, an International Consortium to Accelerate the Development of Comprehensive Treatments Against Tuberculosis C-Path, Ltd. and more than 30 partners from 13 countries participate in the ERA4TB project. The ERA4TB (European Regimen Ac
October 15, 2019 C-Path, CDISC Develop Standard to Represent Data for Animal Rule Studies TUCSON, Ariz. and AUSTIN, Texas, October 15, 2019 — The Critical Path Institute (C-Path) and CDISC are pleased to announc
September 19, 2019 Innovative Data and Analytics Platform to Accelerate Drug Development for Rare Diseases Launched by C-Path and NORD through an FDA grant, the goal of the new platform is to accelerate the development of cures by addres
September 18, 2019 C-Path’s Martha A. Brumfield Named Arizona Bioscience Leader of the Year CHANDLER, Ariz., Sept. 18, 2019 — The Arizona Bioindustry Association (AZBio) today announced that Martha A. Brumf
August 7, 2019 Funded by FDA, C-Path and NORD to Launch Rare Disease Data and Analytics Platform The collaborative project between the organizations will kick off at a launch meeting in September and will aim to r
July 2, 2019 C-Path Taps Medical Science Operations Executive Kristen Swingle as Chief Operating Officer TUCSON, Ariz., July 2, 2019 — The Critical Path Institute (C-Path) is pleased to announce that after an extensive
June 11, 2019 C-Path’s PSTC Releases Points to Consider Outlining Recommendations for Analytical Validation of Assays Used in Qualifying Biomarkers The document serves as a guide to the analysis of biomarkers in drug development TUCSON, Ariz., June 11, 2019 — The Critical Pat